tiprankstipranks
Advertisement
Advertisement
Bicycle Therapeutics: Early EphA2-Targeted Data and Multi-Tumor Expansion Potential Support Buy Rating and Upside to Valuation
PremiumRatingsBicycle Therapeutics: Early EphA2-Targeted Data and Multi-Tumor Expansion Potential Support Buy Rating and Upside to Valuation
3M ago
Bicycle Therapeutics announces updates from EphA2 pipeline at AACR meeting
Premium
The Fly
Bicycle Therapeutics announces updates from EphA2 pipeline at AACR meeting
3M ago
Bicycle Therapeutics Advances EphA2 Oncology Pipeline With New Data
Premium
Company Announcements
Bicycle Therapeutics Advances EphA2 Oncology Pipeline With New Data
3M ago
Bicycle Therapeutics price target lowered to $8 from $12 at Citizens
PremiumThe FlyBicycle Therapeutics price target lowered to $8 from $12 at Citizens
4M ago
Bicycle Therapeutics price target lowered to $8 from $10 at Truist
Premium
The Fly
Bicycle Therapeutics price target lowered to $8 from $10 at Truist
4M ago
Bicycle Therapeutics reports Q4 EPS (29c), consensus (95c)
Premium
The Fly
Bicycle Therapeutics reports Q4 EPS (29c), consensus (95c)
4M ago
Bicycle Therapeutics Sets 2026 Oncology and Radiopharma Priorities
PremiumCompany AnnouncementsBicycle Therapeutics Sets 2026 Oncology and Radiopharma Priorities
6M ago
Bicycle signs 15-year uranium contract with UK Nuclear Decommissioning Authority
Premium
The Fly
Bicycle signs 15-year uranium contract with UK Nuclear Decommissioning Authority
7M ago
Bicycle Therapeutics initiated with a Hold at Truist
Premium
The Fly
Bicycle Therapeutics initiated with a Hold at Truist
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100